Higher basidiomycetes mushrooms as a source of antioxidants

Mikheil D. Asatiani, Vladimir Elisashvili, George Songulashvili, Abraham Z. Reznick, Solomon P. Wasser

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Higher Basidiomycetes represent a taxonomically, ecologically, and physiologically extremely diverse group of eukaryotic organisms. Recently, extensive research on these fungi has markedly increased mainly due to their potential use in a variety of biotechnological applications, particularly for the production of food, enzymes, dietary supplements, and pharmaceutical compounds (Cohen et al., 2002; Wasser, 2002). Many pharmaceutical substances with unique properties were extracted from mushrooms. The cholesterol lowering, anti-diabetic, and immunomodulating compounds are ready for industrial trials and further commercialization, while others are in various stages of development. Some of these substances are not strictly pharmaceutical products (medicines) but rather they represent a novel class of dietary supplements or nutriceuticals. The most important new pharmaceutical products from medicinal mushrooms include polysaccharides, antioxidants, and lectins (Guillot and Konska, 1997; Wasser, 2002; Ng, 2004). In the last few years, there has been significant interest in the use of mushrooms and/or mushroom extracts as dietary supplements based on theories that they enhance immune function and promote health.

Original languageEnglish
Title of host publicationProgress in Mycology
PublisherSpringer Netherlands
Number of pages16
ISBN (Electronic)9789048137138
ISBN (Print)9789048137121
StatePublished - 2010

Bibliographical note

Publisher Copyright:
© 2010 Springer Science+Business Media B.V.

ASJC Scopus subject areas

  • General Agricultural and Biological Sciences


Dive into the research topics of 'Higher basidiomycetes mushrooms as a source of antioxidants'. Together they form a unique fingerprint.

Cite this